Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note Payable (Tables)

6 Months Ended

May 31, 2019

As of May 31, 2019 and November 30, 2018, the note payable obligation was as follows:

	May 31, 2019			November 30, 2018
Note payable	$	11,658,433		$	13,208,433
Unamortized debt issuance costs		(206,922	)		(264,923	)
Net note payable	$	11,451,511		$	12,943,510
Current portion of note payable	$	3,100,000		$	3,100,000
Long-term note payable, net of debt issuance costs		8,351,511			9,843,510
Total	$	11,451,511		$	12,943,510

Interest expense on the note payable for the three and six months ended May 31, 2019 and May 31, 2018 was as follows:

	For the three months ended May 31, 2019		For the six months ended May 31, 2019
Interest expense on notes payable	$	181,440	$	361,682
Debt issuance costs		28,106		58,000
Total Interest expense	$	209,546	$	419,682

	For the three months ended May 31, 2018		For the six months ended May 31, 2018
Interest expense on notes payable	$	94,818	$	188,645
Debt issuance costs		24,837		51,540
Total interest expense	$	119,655	$	240,185